Z 104657A

Drug Profile

Z 104657A

Alternative Names: Non-antibiotic macrolide - Zambon; Z104657A

Latest Information Update: 16 Jul 2016

Price : $50

At a glance

  • Originator Zambon Group SpA
  • Class Macrolides
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Inflammation

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for phase-I development in Inflammation in Europe (PO)
  • 06 Sep 2004 Data presented at the 18th International Symposium of Medicinal Chemistry (ISMC-2004) have been added to the adverse events, pharmacokinetics and Inflammation pharmacodynamics sections
  • 29 Jul 2004 Preclinical trials in Chronic obstructive pulmonary disease in Europe (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top